Talphera (TLPH) Interest Coverage Ratio Growth (3y) (2013 - 2026)
Talphera (TLPH) Interest Coverage Ratio Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.14% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 0.23% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -28.01% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -32.31% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 26.99% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 41.72% |
| 10 | Talphera | 47.31 Mn | 9.48 Mn | - | -166.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -166.65% |
| Dec 31, 2025 | 40.33% |
| Sep 30, 2025 | -44.43% |
| Dec 31, 2024 | 2.87% |
| Sep 30, 2024 | -287.99% |
| Jun 30, 2024 | -274.10% |
| Dec 31, 2023 | 134.54% |
| Sep 30, 2023 | -44.50% |
| Jun 30, 2023 | -73.55% |
| Mar 31, 2023 | 54.34% |
| Dec 31, 2022 | 74.44% |
| Sep 30, 2022 | 32.51% |
| Jun 30, 2022 | -2.25% |
| Mar 31, 2022 | -131.52% |
| Dec 31, 2021 | -28.78% |
| Sep 30, 2021 | 3.09% |
| Jun 30, 2021 | -10.14% |
| Mar 31, 2021 | -1.89% |
| Dec 31, 2020 | -41.26% |
| Sep 30, 2020 | -4.39% |